Pharmaust Limited(DE:ECQ0)
€0.03-0.00 (-3.23%)
DE:ECQ0
Pharmaust Limited financials statements
€0.03
At close:-0.00 (-3.23%)
Pharmaust Limited (ECQ0) Ratios
3 Followers
Pharmaust Limited Ratios
DE:ECQ0's free cash flow for Q4 2026 was AU$-6.58M. For the 2026 fiscal year, DE:ECQ0's free cash flow was decreased by AU$-2.73K and operating cash flow was AU$-6.57M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.16 | 2.84 | 12.42 | 2.24 | 2.24 |
| Quick Ratio | 2.16 | 2.84 | 12.42 | 2.24 | 2.24 |
| Cash Ratio | 1.16 | 2.71 | 10.84 | 2.01 | 2.01 |
| Solvency Ratio | -0.98 | -10.79 | -10.07 | -4.03 | -0.62 |
| Operating Cash Flow Ratio | -1.38 | -9.32 | -5.77 | -1.16 | -0.99 |
| Short-Term Operating Cash Flow Coverage | -4.55 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | AU$ 12.72M | AU$ 2.82M | AU$ 10.23M | AU$ 780.02K | AU$ 787.38K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.14 | 0.00 | 0.00 | 0.17 | 0.17 |
| Debt-to-Equity Ratio | 0.26 | 0.00 | 0.00 | 0.27 | 0.13 |
| Debt-to-Capital Ratio | 0.21 | 0.00 | 0.00 | 0.21 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.86 | 1.55 | 1.09 | 1.58 | 0.78 |
| Debt Service Coverage Ratio | -2.81 | 0.00 | 0.00 | -108.70 | -14.74 |
| Interest Coverage Ratio | -37.65 | 0.00 | 0.00 | -81.34 | -31.06 |
| Debt to Market Cap | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.34 | 0.23 | 1.03 | 0.18 | 1.27 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 0.00% | 0.00% | -32.92% | -6.61% |
| EBIT Margin | -157.83% | 0.00% | 0.00% | -334.76% | -47.90% |
| EBITDA Margin | -157.82% | 0.00% | 0.00% | -334.70% | -38.59% |
| Operating Profit Margin | -157.83% | 0.00% | 0.00% | -235.80% | -81.30% |
| Pretax Profit Margin | -154.01% | 0.00% | 0.00% | -334.76% | -50.52% |
| Net Profit Margin | -60.98% | 0.00% | 0.00% | -319.85% | -50.52% |
| Continuous Operations Profit Margin | -60.98% | 0.00% | 0.00% | -315.16% | -50.52% |
| Net Income Per EBT | 39.59% | 100.00% | 95.55% | 95.55% | 100.00% |
| EBT Per EBIT | 97.58% | 89.81% | 141.97% | 141.97% | 62.14% |
| Return on Assets (ROA) | -45.25% | -380.70% | -81.19% | -147.34% | -27.86% |
| Return on Equity (ROE) | -84.26% | -588.31% | -88.31% | -232.25% | -21.78% |
| Return on Capital Employed (ROCE) | -217.78% | -653.88% | -65.10% | -139.22% | -57.48% |
| Return on Invested Capital (ROIC) | -68.44% | -653.88% | -61.28% | -126.86% | -55.63% |
| Return on Tangible Assets | -45.25% | -380.70% | -81.19% | -298.80% | -56.55% |
| Earnings Yield | -29.31% | -23.30% | -12.49% | -37.52% | -7.70% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.66 | 0.00 | 0.00 | 19.05 | 22.81 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 4.05 | 5.97 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 2277.95 | 0.00 | 0.00 | 1720.84 | 2060.50 |
| Asset Turnover | 0.74 | 0.00 | 0.00 | 0.46 | 0.55 |
| Working Capital Turnover Ratio | 2.26 | 0.00 | 0.00 | 1.69 | 1.51 |
| Cash Conversion Cycle | -690374.94 | 0.00 | -183919.52 | -70.90 | -45.12 |
| Days of Sales Outstanding | 219.47 | 0.00 | 0.00 | 19.16 | 16.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 690594.41 | 0.00 | 183919.52 | 90.06 | 61.12 |
| Operating Cycle | 219.47 | 0.00 | 0.00 | 19.16 | 16.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.02 | -0.03 | -0.01 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.02 | -0.03 | -0.01 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -1833.19 | -9250.89 | -1722855.67 | -44.78 | -30.71 |
| Capital Expenditure Coverage Ratio | -1833.19 | -9250.89 | -1722855.67 | -44.78 | -30.71 |
| Operating Cash Flow Coverage Ratio | -4.55 | 0.00 | 0.00 | -1.49 | -1.27 |
| Operating Cash Flow to Sales Ratio | -0.86 | 0.00 | 0.00 | -0.55 | -0.39 |
| Free Cash Flow Yield | -41.23% | -20.07% | -7.15% | -6.64% | -6.20% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.41 | -4.29 | -8.01 | -2.67 | -12.99 |
| Price-to-Sales (P/S) Ratio | 2.08 | 0.00 | 0.00 | 8.53 | 6.56 |
| Price-to-Book (P/B) Ratio | 2.87 | 25.24 | 7.07 | 6.19 | 2.83 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.43 | -4.98 | -13.99 | -15.06 | -16.12 |
| Price-to-Operating Cash Flow Ratio | -2.43 | -4.98 | -13.99 | -15.39 | -16.65 |
| Price-to-Earnings Growth (PEG) Ratio | 0.06 | -0.08 | -0.31 | -0.01 | 0.00 |
| Enterprise Value Multiple | -0.98 | -3.63 | -6.62 | -2.37 | -15.73 |
| Enterprise Value | 27.20M | 67.04M | 62.59M | 22.42M | 20.52M |
| EV to EBITDA | -0.98 | -3.63 | -6.62 | -2.37 | -15.73 |
| EV to Sales | 1.55 | 0.00 | 0.00 | 7.94 | 6.07 |
| EV to Free Cash Flow | -1.80 | -4.69 | -12.11 | -14.02 | -14.92 |
| EV to Operating Cash Flow | -1.80 | -4.69 | -12.11 | -14.33 | -15.41 |
| Tangible Book Value Per Share | 0.02 | 0.01 | 0.03 | 0.00 | 0.00 |
| Shareholders’ Equity Per Share | 0.02 | 0.01 | 0.03 | 0.01 | 0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.60 | 0.00 | 0.06 | 0.06 | 0.00 |
| Revenue Per Share | 0.03 | 0.00 | 0.00 | 0.01 | 0.01 |
| Net Income Per Share | -0.02 | -0.04 | -0.02 | -0.03 | -0.01 |
| Tax Burden | 0.40 | 1.00 | 0.96 | 0.96 | 1.00 |
| Interest Burden | 0.98 | 0.90 | 1.00 | 1.00 | 1.05 |
| Research & Development to Revenue | 1.20 | 0.00 | 0.00 | 0.37 | 0.22 |
| SG&A to Revenue | 0.38 | 0.00 | 0.00 | 0.59 | 0.52 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | -0.00 | -0.01 |
| Income Quality | 1.41 | 0.86 | 0.71 | 0.25 | 0.78 |
Currency in AUD
